Filing Details
- Accession Number:
- 0001144204-16-141808
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-29 21:54:00
- Reporting Period:
- 2016-12-29
- Filing Date:
- 2016-12-29
- Accepted Time:
- 2016-12-29 21:54:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1621443 | Zynerba Pharmaceuticals Inc. | ZYNE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1405685 | Michael Rapp | 1450 Broadway, 26Th Floor New York NY 10018 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-12-29 | 10,000 | $15.85 | 1,354,115 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
